Brielle Benyon

Patients with metastatic disease whose cancers were tested and treated for specific mutations tended to have better outcomes than those given the standard of care.

After being diagnosed with a type of gynecologic cancer, it is essential for patients to understand the molecular makeup of their disease.

Spleen size, blood counts and symptom burden are some of the factors cancer teams take into account when selecting which of the four JAK inhibitors to treat patient with myelofibrosis.

The recent FDA approval of Lazcluze plus Rybrevant for EGFR-mutant non-small cell lung cancer is a “big deal” for patients, an oncologist said.

From Roger O’Donnell announcing his aggressive lymphoma diagnosis to “Love Is Blind’s” Shaina Hurley opening up about her cervical cancer while three months pregnant, here’s what’s happening in the oncology space this week.

Dr. Partow Kebriaei explains what patients can expect before, during and after an allogeneic stem cell transplant to treat acute lymphoblastic leukemia.

The Food and Drug Administration granted a fast track designation to IBI363 for patients with unresectable advanced or metastatic melanoma.

Researchers are enrolling patients in a trial of ELI-00 7P — a vaccine to treat KRAS-mutant cancer.

From pro wrestling legend Sid Vicious dying of cancer to Nicole Eggert’s breast cancer update, here’s what’s happening in the oncology space this week.

Patients who have a higher risk of head and neck cancer recurrence can expect more — and sooner — monitoring of their disease.

An expert discussed ELI-002 7P, the investigational pancreatic cancer vaccine. He explained how it works and what patients can expect regarding the ongoing research.

Bispecific antibodies connect the immune system with cancer cells. They offer an efficacious treatment option, but there are side effects.

The FDA granted a fast track designation to BGB-16673, a novel drug used to treat chronic lymphocytic leukemia and small lymphocytic lymphoma.

Chemotherapy and radiotherapy may be efficacious enough for certain patients with advanced rectal cancer to avoid surgery, research showed.

From Danielle Fishel and Rick Steves announcing their diagnosis to the “Emily in Paris” star discussing her cancer experience, here’s what’s happening in the oncology space this week.

Researchers investigated the incidence of moderate to severe side effects for patients being treated with a combination of TKI and immunotherapy.

Afinitor did not improve relapse-free survival in patients with non-clear cell renal cell carcinoma — a kidney cancer subtype linked to poor prognosis.

Patients with cancer who did 20-minute guided mindful breathing tended to have a more significant decrease in cancer-related pain and anxiety.

The FDA will speed up their review of Enhertu for HR-positive, HER2-low/ultralow advanced breast cancer that cannot be removed via surgery.

The Food and Drug Administration approved frontline Lazcluze plus Rybrevant for locally advanced or metastatic non-small cell lung cancer with an EGFR exon 19 deletions or exon 21 L858R substitution mutations.

From Susan Wojcicki and Rachael Lillis dying of cancer to the President Biden announcing that Cancer Moonshot initiative received $150 million, here’s what’s happening in the oncology space.

Patients with NSCLC who are overweight or obese should discuss chemotherapy versus immunotherapy for frontline treatment, research showed.

Patients with NSCLC taking five or more medications tended to have worse survival, highlighting the need for medication management, research showed.

The Food and Drug Administration will fast-track the development of AC699 for patients with ER-positive, HER2-negative ESR1-mutant advanced or metastatic breast cancer.

Niktimvo was approved for adults and children with chronic, pretreated graft-versus-host disease.

Patients with blood cancer who undergo CAR-T cell therapy should monitor for fever and signs of respiratory distress, an expert said.

A physical therapist offers tips and exercises that can help patients with cancer who experiencing difficulty walking from either the disease or its treatments.

From “Top Chef’” Shirley Chung and comedian Christina Pazsitzky announcing their diagnoses to Erica Ash’s death from the disease, here is what’s happening in the oncology space this week.

Tecelra is the first cell therapy to be approved for a solid cancer in the United States, and marks the end of a decade-long drought of new drugs for this patient population.

Post-transplant cyclophosphamide decreased the risk of complications in patients with blood cancers who underwent a stem cell transplant from an unrelated donor.